Here’s whether The Chemours Company (CC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.83% over 10 days); strong 1-year return of +127.3%; 3-month momentum positive (+78.0%). Concerns: RSI 79 — overbought, elevated pullback risk. Currently 0.1% off its 52-week high. Score: +5/7.
CC is in a confirmed uptrend, trading above both its 50-day ($20.87) and 200-day ($15.95) moving averages. With an RSI of 78.5, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +127.3% compares to +22.9% for SPY (beat the market by 104.4%).
$10,000 invested 1 year ago→ $22,730 today
vs. S&P 500 (SPY) — same period beat market by 104.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($15.95)
✓Above 50-day MA ($20.87)
!RSI(14) neutral zone (30–70) — currently 78.5
✓Positive return (+127.3%)
✓Within 10% of period high (−0.1%)
Period Range $27.73
$9.13$27.76
RSI (14) 78.5
0 · OversoldOverbought · 100
Key Metrics
Price$27.73
Period Return+127.3%
Period High$27.76
Period Low$9.13
Drawdown−0.1%
MA-50$20.87
MA-200$15.95
RSI (14)78.5
Avg Volume (30d)2.8M
vs. SPYbeat by 98.3%
Return Rank#163 of 1246
Trend Signals
Price is above the 200-day moving average ($15.95)